Back to Portfolio

Oria Bioscience

2025

Oria Bioscience is a biotech platform leveraging organelle-based technologies to improve drug discovery and target validation by enabling more precise analysis of cellular mechanisms.

Website
More details...

Company Overview

CEO
Alexandre Santinho
INVESTED IN
2025
SECTOR
TechBio

Why we invested

  • High barrier to entry driven by proprietary organelle-based technology
  • Breakthrough approach addressing structural inefficiencies in drug discovery
  • Strong R&D depth combined with a credible commercial strategy
  • Early revenues validating market interest beyond pure research use
  • Platform optionality enabling multiple partnering or exit scenarios